Therefore, in order to explore the roles of TGF-β/Smad3 signaling pathway in HCC, we used a newly established in vivo approach, miRNA in vivo precipitation (miRIP)19, which resulted in the successful identification on the previously unpredictable miRNAs that targeted Smad3 mRNA. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.